**Cue Health CEO Transition: From Co-founder to Leadership with Industry Veterans in Advisory Roles**

Cue Health (Nasdaq: HLTH) just shook up its leadership structure, and this move signals something bigger brewing behind the scenes. The healthcare diagnostics company tapped Clint Sever, co-founder and former Chief Product Officer, as its new CEO, replacing Ayub Khattak who steps down from the executive role but remains on the board.

This isn't just a routine promotion. Sever has been building Cue's DNA since day one—14 years of product development, hardware engineering, and scaling manufacturing. He literally designed how Cue's diagnostic systems look and function. Now he's taking the wheel at a time when the company is clearly reassessing its game plan.

**Strategic Reinforcements Arriving**

What's particularly telling is who the board just brought in: Dr. Paul Brown, former President and CEO of Roche Molecular Diagnostics, and Dr. Lisa Danzig, former Global Head of Medical & Scientific Affairs at Grifols. These aren't casual advisor roles—these are heavy hitters in molecular diagnostics and regulatory expertise.

Brown spent decades at Roche scaling diagnostic businesses across virology, blood screening, and infectious diseases. Danzig brings nearly two decades in vaccine and diagnostics development, with hands-on experience navigating FDA processes and commercialization. Translation: Cue Health is bolstering its bench with people who know how to navigate the complex diagnostics industry.

**What's Really Happening**

The real story here is the "comprehensive review" Cue is launching across its business and operations. That's corporate speak for: we're rethinking our strategy and trimming costs. The company has FDA approvals for COVID-19 and Mpox tests, owns over 100 patents, and is headquartered in San Diego—but clearly the board sees room to sharpen execution.

Khattak's parting message hints at this too: he's proud of bringing "lab-quality molecular diagnostics into the home," but the future requires refined strategy and operational efficiency. With Sever at the helm and industry veterans whispering in the board's ear, Cue Health seems positioned to enter its next phase with both founder passion and institutional discipline backing the play.